LAURA TOPPER: Open Payments
NPI 1649306655 · TAKOMA PARK, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$398 in 20 payments from 14 companies in 2025. Trend: 2023 $568 · 2024 $549 · 2025 $398
Food & beverage: $398
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 3 | $72 |
| Novartis Pharmaceuticals Corporation | 3 | $47 |
| Corcept Therapeutics | 2 | $37 |
| HARMONY BIOSCIENCES LLC | 1 | $28 |
| CARDIVA MEDICAL, INC. | 1 | $27 |
| Novo Nordisk Inc | 1 | $27 |
| Neurelis, Inc. | 1 | $24 |
| Actelion Pharmaceuticals US, Inc. | 1 | $24 |
| GlaxoSmithKline, LLC. | 1 | $22 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 2 | $20 |
Products named: VYNDAQEL, LEQVIO, Korlym, WAKIX, CARDIVA VASCADE MVP VVCS 6-12F, Wegovy, VALTOCO, UPTRAVI.
Industry payments across MD — which companies pay providers there.
